VUPAXTA Trademark

Trademark Overview

On Thursday, July 17, 2014, a trademark application was filed for VUPAXTA with the United States Patent and Trademark Office. The USPTO has given the VUPAXTA trademark a serial number of 86340022. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 2, 2017. This trademark is owned by Novartis AG. The VUPAXTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in human medicine for the treatment of multiple sclerosis
vupaxta

General Information

Serial Number86340022
Word MarkVUPAXTA
Filing DateThursday, July 17, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 2, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in human medicine for the treatment of multiple sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 23, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Tuesday, January 3, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 2, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 25, 2016EXTENSION 2 GRANTED
Tuesday, May 24, 2016EXTENSION 2 FILED
Saturday, June 25, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 24, 2016TEAS EXTENSION RECEIVED
Saturday, November 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 19, 2015EXTENSION 1 GRANTED
Thursday, November 19, 2015EXTENSION 1 FILED
Thursday, November 19, 2015TEAS EXTENSION RECEIVED
Tuesday, May 26, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 24, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 16, 2015ASSIGNED TO LIE
Monday, February 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 18, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 18, 2014NON-FINAL ACTION E-MAILED
Monday, August 18, 2014NON-FINAL ACTION WRITTEN
Friday, August 15, 2014ASSIGNED TO EXAMINER
Wednesday, July 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 21, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

vupaxta multiple sclerosis treatment medicine preparations human pharmaceutical